קאַמישאַן שטעלט אַ ריווייזד אַרויספירן דורכזעיקייַט און דערלויבעניש מעקאַניזאַם און מיטלען פֿאַר אַקסעלערייטיד האַסקאָמע פון ​​אַדאַפּטיד וואַקסינז קעגן COVID-19 וועריאַנץ.

The European Commission has introduced the principles of reciprocity and proportionality as new criteria to be considered for authorizing exports under the transparency and authorisation mechanism for COVID-19 vaccine exports. This system has significantly improved the transparency of exports. Nevertheless, the objective to ensure timely access to COVID-19 vaccines for EU citizens is still not met. A press release is available אָנליין.

Also, as an immediate action under the HERA Incubator, the new European bio-defence preparedness plan against COVID-19 variants, the Commission is introducing a measure to speed up the authorisation of adapted COVID-19 vaccines. It will make provisions in the relevant EU legislation to allow companies to focus on gathering the necessary evidence in time and enable the authorisation of adapted vaccines with a smaller set of additional data submitted to the European Medicines Agency. A press release is available דאָ.

You can follow the press conference by Executive Vice-President Valdis Dombrovskis and Commissioner Stella Kyriakides on EBS.

שער דעם אַרטיקל: